Related Experiment Video
Updated: Aug 13, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
Novel protein kinases in pancreatic cell growth and cancer
1Department of Internal Medicine, Medical University of Ulm/Germany, Abt. Innere Medizin I, Medizinische Universitaetsklinik Ulm, Robert-Koch Str 8, D-89081 Ulm, Germany. thomas.seufferlein@medizin.uni-ulm.de
Abstract:
The network of enzymes that contribute to the signal transduction of extracellular factors in pancreatic cancer is ever increasing. The classical Raf-MEK-ERK signaling cascade plays a crucial role in the regulation of apoptosis, proliferation, and metastasis of pancreatic cancer. Phosphatidylinositide-3-kinase also contributes to growth and prevents apoptosis in pancreatic cancer cells, acting in part via its downstream targets, PKB/AKT and the FRAP/p70s6k signaling complex. Recently, members of the PKC family of serine threonine kinases have emerged as novel modulators of transformation and cell cycle progression of pancreatic cancers. The novel PKD family of serine threonine kinases has just been detected in pancreatic cancer and awaits its functional characterization in these tumors.
Insights
Pancreatic cancer signaling involves multiple enzyme pathways, including Raf-MEK-ERK and phosphatidylinositide-3-kinase. Novel protein kinase D (PKD) family kinases are newly detected and require functional characterization in pancreatic tumors.
Area of Science:
- Oncology
- Molecular Biology
- Signal Transduction
Background:
- Extracellular signaling pathways are critical in pancreatic cancer.
- The Raf-MEK-ERK cascade regulates apoptosis, proliferation, and metastasis.
- Phosphatidylinositide-3-kinase signaling, via PKB/AKT and FRAP/p70s6k, promotes growth and inhibits apoptosis.
Purpose of the Study:
- To highlight the expanding network of signaling enzymes in pancreatic cancer.
- To introduce the role of protein kinase C (PKC) family kinases.
- To report the recent detection of the novel protein kinase D (PKD) family in pancreatic cancer and emphasize the need for functional characterization.
Main Methods:
- Literature review of signaling pathways in pancreatic cancer.
- Analysis of enzyme families involved in pancreatic cancer.
- Identification of novel kinase families in tumor tissues.
Main Results:
- The Raf-MEK-ERK pathway is crucial for pancreatic cancer progression.
- Phosphatidylinositide-3-kinase signaling pathways are implicated in cell growth and survival.
- Protein kinase C (PKC) and protein kinase D (PKD) families are emerging as key modulators.
Conclusions:
- Multiple enzyme networks significantly influence pancreatic cancer.
- PKC family kinases modulate transformation and cell cycle.
- PKD family kinases represent a novel target for functional studies in pancreatic cancer.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

